Products Products
Mutual Funds
Stock Market
NPS Retirement Funds

Company Company
About us
Contact us
1000003197
Paytm
Mutual Funds Stock Market NPS Retirement Funds
About us Contact us

Transgene Biotek

4.29
- (NaN%) tick BSE

Buy Sell

Last updated on 20 Jun 2025 12:31 PM

Returns
0.94%
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

32.51

Earning Per Share

-0.09

Dividend Yield

-%

P/E Ratio

-

P/B Ratio

-4.29

Debt to Equity

-

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value
down-img

5.34% down side

up side5.34%

ups-img

About the company

Founded in March, 1990 by Dr. Koteswara Rao, Transgene Biotek Ltd was one of the first Biotechnology companies in India. Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc. The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

Similar Companies


Login